Skip to content

Clinical trials

Phase 2 Community-Acquired Pneumonia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Community-Acquired Pneumonia Phase: Phase 2 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20101
20141
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aptarion Biotech AG1
Enanta Pharmaceuticals, Inc1
Gordon Bernard1
IASO Pharma Inc.1
ICOS Corporation1
Melinta Therapeutics, Inc.1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Community-Acquired Pneumonia7
Pneumonia4
Cognition Disorders1
Lymphoma, Follicular1
Sepsis1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.